NTP meeting
This article was originally published in The Rose Sheet
Executive Summary
Development of roadmap for implementation of the National Toxicology Program "Vision for the 21st Century," activities of the NTP Board's Technical Reports Review Subcommittee and an update on the Report on Carcinogens, 11th edition, will be addressed at a June 29 meeting of the NTP Board of Scientific Counselors, NTP announces in June 8 Federal Register 1notice. Written comments on agenda items are due June 21...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.